Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

Capellini, A., Etra, A., Alousi, A. M., Al Malki, M. M., Choe, H., Defilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F. A., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E. O., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2022). Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy. Blood, 140(Supplement 1), 1867–1869. https://doi.org/10.1182/blood-2022-156000
Authors:
Alexandra Capellini
Aaron Etra
Amin M. Alousi
Monzr M. Al Malki
Hannah Choe
Zachariah DeFilipp
William J. Hogan
Carrie L. Kitko
Francis Ayuk
Janna Baez
Isha Gandhi
Stelios Kasikis
Sigrun Gleich
Elizabeth O. Hexner
Matthias Hoepting
Urvi Kapoor
Steven Kowalyk
Deukwoo Kwon
Amelia Langston
Marco Mielcarek
George Morales
Umut Özbek
Muna Qayed
Ran Reshef
Wolf Roesler
Nikolaos Spyrou
Rachel Young
Yi‐Bin Chen
James L.M. Ferrara
John E. Levine
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Hematopoietic Stem Cell Biology (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-156000
DOI:
10.1182/blood-2022-156000
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: